{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:51:38Z","timestamp":1768647098985,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Approximately 10\u201320% of patients with primary biliary cholangitis (PBC) progress to jaundice stage regardless of treatment with ursodeoxycholic acid and bezafibrate. In this study, we performed a GWAS and a replication study to identify genetic variants associated with jaundice-stage progression in PBC using a total of 1,375 patients (1,202 early-stage and 173 jaundice-stage) in a Japanese population. SNP rs13720, which is located in the 3\u2032UTR of<jats:italic>cathepsin Z<\/jats:italic>(<jats:italic>CTSZ<\/jats:italic>), showed the strongest association (odds ratio [OR]\u2009=\u20092.15,<jats:italic>P<\/jats:italic>\u2009=\u20097.62\u2009\u00d7\u200910<jats:sup>\u22127<\/jats:sup>) with progression to jaundice stage in GWAS. High-density association mapping at the<jats:italic>CTSZ<\/jats:italic>and<jats:italic>negative elongation factor complex member C\/D<\/jats:italic>(<jats:italic>NELFCD<\/jats:italic>) loci, which are located within a strong linkage disequilibrium (LD) block, revealed that an intronic SNP of<jats:italic>CTSZ<\/jats:italic>, rs163800, was significantly associated with jaundice-stage progression (OR\u2009=\u20092.16,<jats:italic>P<\/jats:italic>\u2009=\u20098.57\u2009\u00d7\u200910<jats:sup>\u22128<\/jats:sup>). In addition, eQTL analysis and<jats:italic>in silico<\/jats:italic>functional analysis indicated that genotypes of rs163800 or variants in strong LD with rs163800 influence expression levels of both<jats:italic>NELFCD<\/jats:italic>and<jats:italic>CTSZ<\/jats:italic>mRNA. The present novel findings will contribute to dissect the mechanism of PBC progression and also to facilitate the development of therapies for PBC patients who are resistant to current therapies.<\/jats:p>","DOI":"10.1038\/s41598-018-26369-6","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T14:11:55Z","timestamp":1526566315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["NELFCD and CTSZ loci are associated with jaundice-stage progression in primary biliary cholangitis in the Japanese population"],"prefix":"10.1038","volume":"8","author":[{"given":"Nao","family":"Nishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hitomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minae","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyo","family":"Yamashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumito","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhisa","family":"Takatsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6358-5283","authenticated-orcid":false,"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsumasa","family":"Komori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kokudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"26369_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan, M. M. & Gershwin, M. E. Primary biliary cirrhosis. N Engl J Med 353, 1261\u20131273 (2005).","journal-title":"N Engl J Med"},{"key":"26369_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper, E. M. et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 136, 1281\u20131287 (2009).","journal-title":"Gastroenterology"},{"key":"26369_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00535-014-0998-z","volume":"50","author":"A Tanaka","year":"2015","unstructured":"Tanaka, A., Hirohara, J., Nakanuma, Y., Tsubouchi, H. & Takikawa, H. Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA. J Gastroenterol 50, 675\u2013682 (2015).","journal-title":"J Gastroenterol"},{"key":"26369_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura, M. et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45, 118\u2013127 (2007).","journal-title":"Hepatology"},{"key":"26369_CR5","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers, W. J. et al. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy. Gastroenterology 149, 1804\u20131812 e1804 (2015).","journal-title":"Gastroenterology"},{"key":"26369_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone, M. et al. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology 63, 930\u2013950 (2016).","journal-title":"Hepatology"},{"key":"26369_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","volume":"127","author":"C Selmi","year":"2004","unstructured":"Selmi, C. et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127, 485\u2013492 (2004).","journal-title":"Gastroenterology"},{"key":"26369_CR8","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","volume":"360","author":"GM Hirschfield","year":"2009","unstructured":"Hirschfield, G. M. et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360, 2544\u20132555 (2009).","journal-title":"N Engl J Med"},{"key":"26369_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ng.631","volume":"42","author":"GM Hirschfield","year":"2010","unstructured":"Hirschfield, G. M. et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 42, 655\u2013657 (2010).","journal-title":"Nat Genet"},{"key":"26369_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/ng.789","volume":"43","author":"GF Mells","year":"2011","unstructured":"Mells, G. F. et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 43, 329\u2013332 (2011).","journal-title":"Nat Genet"},{"key":"26369_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ng.627","volume":"42","author":"X Liu","year":"2010","unstructured":"Liu, X. et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 42, 658\u2013660 (2010).","journal-title":"Nat Genet"},{"key":"26369_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/gene.2011.89","volume":"13","author":"GM Hirschfield","year":"2012","unstructured":"Hirschfield, G. M. et al. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun 13, 328\u2013335 (2012).","journal-title":"Genes Immun"},{"key":"26369_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/ng.2395","volume":"44","author":"JZ Liu","year":"2012","unstructured":"Liu, J. Z. et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet 44, 1137\u20131141 (2012).","journal-title":"Nat Genet"},{"key":"26369_CR14","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1093\/hmg\/dds359","volume":"21","author":"BD Juran","year":"2012","unstructured":"Juran, B. D. et al. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet 21, 5209\u20135221 (2012).","journal-title":"Hum Mol Genet"},{"key":"26369_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9019","volume":"6","author":"HJ Cordell","year":"2015","unstructured":"Cordell, H. J. et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat Commun 6, 8019 (2015).","journal-title":"Nat Commun"},{"key":"26369_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","volume":"91","author":"M Nakamura","year":"2012","unstructured":"Nakamura, M. et al. Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet 91, 721\u2013728 (2012).","journal-title":"Am J Hum Genet"},{"key":"26369_CR17","first-page":"650","volume":"26","author":"M Kawashima","year":"2017","unstructured":"Kawashima, M. et al. Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population. Hum Mol Genet 26, 650\u2013659 (2017).","journal-title":"Hum Mol Genet"},{"key":"26369_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14828","volume":"8","author":"F Qiu","year":"2017","unstructured":"Qiu, F. et al. A genome-wide association study identifies six novel risk loci for primary biliary cholangitis. Nat Commun 8, 14828 (2017).","journal-title":"Nat Commun"},{"key":"26369_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/hep.22382","volume":"48","author":"Y Ohishi","year":"2008","unstructured":"Ohishi, Y. et al. Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis. Hepatology 48, 853\u2013862 (2008).","journal-title":"Hepatology"},{"key":"26369_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00535-011-0417-7","volume":"46","author":"Y Aiba","year":"2011","unstructured":"Aiba, Y. et al. Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. J Gastroenterol 46, 1203\u20131212 (2011).","journal-title":"J Gastroenterol"},{"key":"26369_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s00535-012-0730-9","volume":"48","author":"T Inamine","year":"2013","unstructured":"Inamine, T. et al. Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients. J Gastroenterol 48, 1160\u20131170 (2013).","journal-title":"J Gastroenterol"},{"key":"26369_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s00535-010-0351-0","volume":"46","author":"T Inamine","year":"2011","unstructured":"Inamine, T. et al. A polymorphism in the integrin alphaV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients. J Gastroenterol 46, 676\u2013686 (2011).","journal-title":"J Gastroenterol"},{"key":"26369_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1164\/rccm.200710-1554OC","volume":"178","author":"GS Cooke","year":"2008","unstructured":"Cooke, G. S. et al. Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am J Respir Crit Care Med 178, 203\u2013207 (2008).","journal-title":"Am J Respir Crit Care Med"},{"key":"26369_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.humimm.2011.02.016","volume":"72","author":"AR Baker","year":"2011","unstructured":"Baker, A. R. et al. Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study. Hum Immunol 72, 426\u2013430 (2011).","journal-title":"Hum Immunol"},{"key":"26369_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ejhg.2011.1","volume":"19","author":"LA Adams","year":"2011","unstructured":"Adams, L. A. et al. Polymorphisms in MC3R promoter and CTSZ 3\u2032UTR are associated with tuberculosis susceptibility. Eur J Hum Genet 19, 676\u2013681 (2011).","journal-title":"Eur J Hum Genet"},{"key":"26369_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.semcancer.2014.05.001","volume":"31","author":"J Kos","year":"2015","unstructured":"Kos, J., Vizin, T., Fonovic, U. P. & Pislar, A. Intracellular signaling by cathepsin X: molecular mechanisms and diagnostic and therapeutic opportunities in cancer. Semin Cancer Biol 31, 76\u201383 (2015).","journal-title":"Semin Cancer Biol"},{"key":"26369_CR27","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1128\/MCB.23.6.1863-1873.2003","volume":"23","author":"T Narita","year":"2003","unstructured":"Narita, T. et al. Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Mol Cell Biol 23, 1863\u20131873 (2003).","journal-title":"Mol Cell Biol"},{"key":"26369_CR28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jcb.22484","volume":"109","author":"Y Yang","year":"2010","unstructured":"Yang, Y. et al. Trihydrophobin 1 attenuates androgen signal transduction through promoting androgen receptor degradation. J Cell Biochem 109, 1013\u20131024 (2010).","journal-title":"J Cell Biochem"},{"key":"26369_CR29","doi-asserted-by":"publisher","first-page":"8786","DOI":"10.1074\/jbc.M806144200","volume":"284","author":"C Cheng","year":"2009","unstructured":"Cheng, C. et al. Trihydrophobin 1 Interacts with PAK1 and Regulates ERK\/MAPK Activation and Cell Migration. J Biol Chem 284, 8786\u20138796 (2009).","journal-title":"J Biol Chem"},{"key":"26369_CR30","doi-asserted-by":"publisher","first-page":"10167","DOI":"10.1074\/jbc.M307994200","volume":"279","author":"W Liu","year":"2004","unstructured":"Liu, W. et al. Trihydrophobin 1 is a new negative regulator of A-Raf kinase. J Biol Chem 279, 10167\u201310175 (2004).","journal-title":"J Biol Chem"},{"key":"26369_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/FJC.0b013e318226bd16","volume":"58","author":"J Sun","year":"2011","unstructured":"Sun, J. et al. Attenuation of atherogenesis via the anti-inflammatory effects of the selective estrogen receptor beta modulator 8beta-VE2. J Cardiovasc Pharmacol 58, 399\u2013405 (2011).","journal-title":"J Cardiovasc Pharmacol"},{"key":"26369_CR32","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1111\/j.1349-7006.2010.01656.x","volume":"101","author":"W Zou","year":"2010","unstructured":"Zou, W. et al. Negative role of trihydrophobin 1 in breast cancer growth and migration. Cancer Sci 101, 2156\u20132162 (2010).","journal-title":"Cancer Sci"},{"key":"26369_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jhep.2004.08.022","volume":"41","author":"D Alvaro","year":"2004","unstructured":"Alvaro, D. et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 41, 905\u2013912 (2004).","journal-title":"J Hepatol"},{"key":"26369_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/apt.13927","volume":"45","author":"F Yang","year":"2017","unstructured":"Yang, F. et al. The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210. Aliment Pharmacol Ther 45, 733\u2013743 (2017).","journal-title":"Aliment Pharmacol Ther"},{"key":"26369_CR35","doi-asserted-by":"publisher","first-page":"e29967","DOI":"10.1371\/journal.pone.0029967","volume":"7","author":"N Nishida","year":"2012","unstructured":"Nishida, N., Mawatari, Y., Sageshima, M. & Tokunaga, K. Highly parallel and short-acting amplification with locus-specific primers to detect single nucleotide polymorphisms by the DigiTag2 assay. PLoS One 7, e29967 (2012).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26369-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T21:03:09Z","timestamp":1720299789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26369-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26369-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"31 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8071"}}